AZTA
Azenta, Inc.
NasdaqGS Healthcare United States
35,73 $US
+2.55% today
+7.01% YTD · +12.32% 1Y
7
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
17
Hedge funds tracked
Latest available SEC 13F filings
66
/ 100
STRONG

Analysis Azenta, Inc. (AZTA) — Kairos Score 66/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Azenta, Inc.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Key info

👔
CEO
Dr. Martin D. Madaus D.V.M., Ph.D.
📍
HQ
200 Summit Drive, 6th Floor, Burlington, MA, 01803, United States
👥
Employees
2 900
💰
Market cap
1 565 273 856,00 $US
💸
Dividend yield
0.00%

🕴️ Insider activity (90 days)

7 transactions — 0 buys and 0 sales reported by Azenta, Inc. executives.

MM
Madaus Martin D
Interim CEO · 2026-09-22
Other
BE
Bello Erik J.
VP Chief Accounting Officer · 2026-09-15
Other
MM
Madaus Martin D
Interim CEO · 2026-09-14
Other

🏦 Hedge Funds

17 institutional funds report a position on AZTA in their latest SEC quarterly filing.

BlackRock, Inc.
VANGUARD GROUP INC
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
STATE STREET CORP

📰 Recent news

15 recent articles on AZTA.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Azenta, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of AZTA on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 7 insider transactions over 90 days
✅ All 17 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year